• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Action of 1-isonicotinyl-2-palmitoyl hydrazine against the Mycobacterium avium complex and enhancement of its activity by m-fluorophenylalanine.1-异烟酰基-2-棕榈酰肼对鸟分枝杆菌复合群的作用以及间氟苯丙氨酸对其活性的增强作用。
Antimicrob Agents Chemother. 1990 Nov;34(11):2061-4. doi: 10.1128/AAC.34.11.2061.
2
Antibacterial action of amphipathic derivatives of isoniazid against the Mycobacterium avium complex.
Zentralbl Bakteriol Mikrobiol Hyg A. 1988 Jun;268(4):456-62. doi: 10.1016/s0176-6724(88)80123-8.
3
Activity of subinhibitory concentrations of dapsone alone and in combination with cell-wall inhibitors against Mycobacterium avium complex organisms.
Eur J Clin Microbiol Infect Dis. 1993 Dec;12(12):954-8. doi: 10.1007/BF01992173.
4
Enhancement of drug susceptibility of Mycobacterium avium by inhibitors of cell envelope synthesis.通过细胞壁合成抑制剂增强鸟分枝杆菌的药物敏感性。
Antimicrob Agents Chemother. 1990 May;34(5):759-64. doi: 10.1128/AAC.34.5.759.
5
JVA, an isoniazid analogue, is a bioactive compound against a clinical isolate of the Mycobacterium avium complex.JVA,一种异烟肼类似物,是一种针对鸟分枝杆菌复合体临床分离株的活性化合物。
Tuberculosis (Edinb). 2019 Mar;115:108-112. doi: 10.1016/j.tube.2019.03.002. Epub 2019 Mar 5.
6
[Antimycobacterial activity of isoniazid (INH) in the presence of prothionamid (PTH) and diaminodiphenylsulfone (DDS) in vitro].[异烟肼(INH)在丙硫异烟胺(PTH)和氨苯砜(DDS)存在下的体外抗分枝杆菌活性]
Infection. 1974;2(2):80-1. doi: 10.1007/BF01642026.
7
In vitro bactericidal activity of oxazolidinone, RBx 8700 against Mycobacterium tuberculosis and Mycobacterium avium complex.恶唑烷酮类药物RBx 8700对结核分枝杆菌和鸟分枝杆菌复合群的体外杀菌活性
J Chemother. 2006 Apr;18(2):144-50. doi: 10.1179/joc.2006.18.2.144.
8
Variation in isoniazid susceptibility of Mycobacterium avium during the cell cycle.鸟分枝杆菌在细胞周期中对异烟肼敏感性的变化。
Am Rev Respir Dis. 1981 Apr;123(4 Pt 1):450-3. doi: 10.1164/arrd.1981.123.4.450.
9
Activities of fluoroquinolone, macrolide, and aminoglycoside drugs combined with inhibitors of glycosylation and fatty acid and peptide biosynthesis against Mycobacterium avium.氟喹诺酮类、大环内酯类和氨基糖苷类药物与糖基化、脂肪酸及肽生物合成抑制剂联合应用对鸟分枝杆菌的活性
Antimicrob Agents Chemother. 1993 Apr;37(4):652-61. doi: 10.1128/AAC.37.4.652.
10
Antimycobacterial activity of isoniazid + prothionamide + dapsone against a number of randomly selected 'wild' strains of Mycobacterium tuberculosis.异烟肼+丙硫异烟胺+氨苯砜对若干随机挑选的结核分枝杆菌“野生”菌株的抗分枝杆菌活性。
Chemotherapy. 1980;26(4):276-81. doi: 10.1159/000237917.

引用本文的文献

1
Preparation and antitubercular activities in vitro and in vivo of novel Schiff bases of isoniazid.异烟肼新型席夫碱的制备及其体外和体内抗结核活性
Eur J Med Chem. 2009 Oct;44(10):4169-78. doi: 10.1016/j.ejmech.2009.05.009. Epub 2009 May 21.
2
Multidrug-resistant Mycobacterium tuberculosis: molecular perspectives.耐多药结核分枝杆菌:分子视角
Emerg Infect Dis. 1998 Apr-Jun;4(2):195-209. doi: 10.3201/eid0402.980207.
3
Activities of fluoroquinolone, macrolide, and aminoglycoside drugs combined with inhibitors of glycosylation and fatty acid and peptide biosynthesis against Mycobacterium avium.氟喹诺酮类、大环内酯类和氨基糖苷类药物与糖基化、脂肪酸及肽生物合成抑制剂联合应用对鸟分枝杆菌的活性
Antimicrob Agents Chemother. 1993 Apr;37(4):652-61. doi: 10.1128/AAC.37.4.652.
4
Potential drug targets for Mycobacterium avium defined by radiometric drug-inhibitor combination techniques.通过放射性药物抑制剂联合技术确定的鸟分枝杆菌潜在药物靶点。
Antimicrob Agents Chemother. 1994 Oct;38(10):2287-95. doi: 10.1128/AAC.38.10.2287.
5
In vitro activity of the new difluorinated quinolone sparfloxacin (AT-4140) against Mycobacterium tuberculosis compared with activities of ofloxacin and ciprofloxacin.新型二氟喹诺酮类药物司帕沙星(AT - 4140)对结核分枝杆菌的体外活性与氧氟沙星和环丙沙星活性的比较
Antimicrob Agents Chemother. 1991 Sep;35(9):1933-6. doi: 10.1128/AAC.35.9.1933.
6
Extracellular and intracellular activities of clarithromycin used alone and in association with ethambutol and rifampin against Mycobacterium avium complex.克拉霉素单独使用以及与乙胺丁醇和利福平联合使用时对鸟分枝杆菌复合群的细胞外和细胞内活性。
Antimicrob Agents Chemother. 1991 Mar;35(3):462-70. doi: 10.1128/AAC.35.3.462.
7
Antimycobacterial spectrum of sparfloxacin and its activities alone and in association with other drugs against Mycobacterium avium complex growing extracellularly and intracellularly in murine and human macrophages.司帕沙星的抗分枝杆菌谱及其单独使用和与其他药物联合使用时对在小鼠和人类巨噬细胞胞外和胞内生长的鸟分枝杆菌复合群的活性。
Antimicrob Agents Chemother. 1991 Dec;35(12):2473-80. doi: 10.1128/AAC.35.12.2473.
8
Activity of clarithromycin compared with those of other drugs against Mycobacterium paratuberculosis and further enhancement of its extracellular and intracellular activities by ethambutol.克拉霉素与其他药物抗副结核分枝杆菌的活性比较以及乙胺丁醇对其细胞外和细胞内活性的进一步增强作用。
Antimicrob Agents Chemother. 1992 Dec;36(12):2843-6. doi: 10.1128/AAC.36.12.2843.

本文引用的文献

1
Basis for lack of drug susceptibility of atypical mycobacteria.非结核分枝杆菌耐药的基础。
Rev Infect Dis. 1981 Sep-Oct;3(5):878-84. doi: 10.1093/clinids/3.5.878.
2
Variation in isoniazid susceptibility of Mycobacterium avium during the cell cycle.鸟分枝杆菌在细胞周期中对异烟肼敏感性的变化。
Am Rev Respir Dis. 1981 Apr;123(4 Pt 1):450-3. doi: 10.1164/arrd.1981.123.4.450.
3
Multiple drug resistance in Mycobacterium avium: is the wall architecture responsible for exclusion of antimicrobial agents?鸟分枝杆菌中的多重耐药性:细胞壁结构是抗菌药物排除的原因吗?
Antimicrob Agents Chemother. 1981 Nov;20(5):666-77. doi: 10.1128/AAC.20.5.666.
4
Utilization of palmitic acid by Mycobacterium avium.鸟分枝杆菌对棕榈酸的利用
Infect Immun. 1971 Sep;4(3):199-204. doi: 10.1128/iai.4.3.199-204.1971.
5
Effect of palmitic acid utilization on cell division in Mycobacterium avium.棕榈酸利用对鸟分枝杆菌细胞分裂的影响。
Infect Immun. 1974 Feb;9(2):363-72. doi: 10.1128/iai.9.2.363-372.1974.
6
Medical therapy of Mycobacterium avium-intracellulare pulmonary disease.
Am Rev Respir Dis. 1986 Sep;134(3):442-5. doi: 10.1164/arrd.1986.134.3.442.
7
Uptake of selected antibacterial agents in Mycobacterium avium.
Zentralbl Bakteriol Mikrobiol Hyg A. 1987 Jul;265(3-4):385-92.
8
Structure of the cell envelope of Mycobacterium avium.鸟分枝杆菌细胞包膜的结构
Zentralbl Bakteriol Mikrobiol Hyg A. 1987 Apr;264(1-2):49-66. doi: 10.1016/s0176-6724(87)80124-4.
9
Mycobacterial infections in AIDS patients, with an emphasis on the Mycobacterium avium complex.艾滋病患者的分枝杆菌感染,重点是鸟分枝杆菌复合体。
Rev Infect Dis. 1986 Nov-Dec;8(6):1024-33. doi: 10.1093/clinids/8.6.1024.
10
Synergistic effects of antimycobacterial drug combinations on Mycobacterium avium complex determined radiometrically in liquid medium.在液体培养基中通过放射性测定法确定抗分枝杆菌药物组合对鸟分枝杆菌复合群的协同作用。
Eur J Clin Microbiol. 1987 Oct;6(5):530-5. doi: 10.1007/BF02014241.

1-异烟酰基-2-棕榈酰肼对鸟分枝杆菌复合群的作用以及间氟苯丙氨酸对其活性的增强作用。

Action of 1-isonicotinyl-2-palmitoyl hydrazine against the Mycobacterium avium complex and enhancement of its activity by m-fluorophenylalanine.

作者信息

Rastogi N, Goh K S

机构信息

Unité de la Tuberculose et des Mycobactéries, Institute Pasteur, Paris, France.

出版信息

Antimicrob Agents Chemother. 1990 Nov;34(11):2061-4. doi: 10.1128/AAC.34.11.2061.

DOI:10.1128/AAC.34.11.2061
PMID:2073098
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC171999/
Abstract

In the present work, we investigated whether resistance to isoniazid (INH) of organisms belonging to the Mycobacterium avium complex was caused by the bacterial cell envelope, with the cell wall and the outer layer acting as an exclusion barrier. We observed that this exclusion barrier was most efficient in excluding the hydrophilic drug INH, as this drug could not penetrate a wall matrix formed of various polymethylated lipidic or amphipathic substances. Two main strategies were proposed for circumventing this drug resistance: (i) synthesis of amphipathic derivatives of otherwise highly hydrophilic drugs and (ii) inhibition of synthesis of the bacterial outer layer. The purpose of this work was to demonstrate that attaching a palmitic acid side chain to INH rendered it growth inhibitory against M. avium complex bacteria and that the concomitant use of this amphipathic INH derivative with m-fluorophenylalanine (an inhibitor of mycoside C biosynthesis which causes the disruption of the bacterial outer layer) resulted in further enhancement of its activity, leading to a bactericidal effect.

摘要

在本研究中,我们调查了鸟分枝杆菌复合群中各生物体对异烟肼(INH)的耐药性是否由细菌细胞壁引起,其中细胞壁和外层起着排斥屏障的作用。我们观察到,这种排斥屏障在排除亲水性药物INH方面最为有效,因为这种药物无法穿透由各种多甲基化脂质或两亲性物质形成的壁基质。提出了两种规避这种耐药性的主要策略:(i)合成原本高度亲水性药物的两亲性衍生物,以及(ii)抑制细菌外层的合成。本研究的目的是证明,将棕榈酸侧链连接到INH上可使其对鸟分枝杆菌复合群细菌具有生长抑制作用,并且这种两亲性INH衍生物与间氟苯丙氨酸(一种导致细菌外层破坏的霉菌酸C生物合成抑制剂)同时使用会进一步增强其活性,从而产生杀菌效果。